Stabilized insulin-like growth factor polypeptides

Details for Australian Patent Application No. 2007257936 (hide)

Owner Novartis AG

Inventors Fornaro, Mara; Glass, David Jonathan

Agent Davies Collison Cave

Pub. Number AU-B-2007257936

PCT Pub. Number WO2007/146689

Priority 60/812,349 09.06.06 US; 60/897,187 24.01.07 US; 60/862,244 20.10.06 US

Filing date 6 June 2007

Wipo publication date 21 December 2007

Acceptance publication date 26 May 2011

International Classifications

C07K 14/65 (2006.01) Peptides having more than 20 amino acids

A61K 38/30 (2006.01) Medicinal preparations containing peptides - Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2

Event Publications

4 December 2008 PCT application entered the National Phase

  PCT publication WO2007/146689 Priority application(s): WO2007/146689

26 May 2011 Application Accepted

  Published as AU-B-2007257936

22 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007257940-Progressive award selection in a wager game

2007257934-Snore detection and confirmation